Brief: Harpoon Therapeutics Says Net Loss For Q2 Ended June 30, 2021 Was $16.8 Million
Aug 5 (Reuters) - Harpoon Therapeutics Inc HARP.O :
* HARPOON THERAPEUTICS REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* REVENUE FOR Q2 ENDED JUNE 30, 2021 WAS $5.8 MILLION
* NET LOSS FOR Q2 ENDED JUNE 30, 2021 WAS $16.8 MILLION
* Q2 REVENUE VIEW $6.9 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX71mgyc
Further company coverage: HARP.O
Recent news on Harpoon Therapeutics
See all newsBrief: Harpoon Therapeutics Receives 17 Additional Demands Seeking Disclosures in Proxy Statement
U.S. RESEARCH ROUNDUP-Axonics, BlackRock, Credit Acceptance
U.S. STOCKS ON THE MOVE-Core & Main, Commercial Metals, Equifax
U.S. STOCKS ON THE MOVE-Toll Brothers, American Eagle Outfitters, Twilio
Wrapup 1: Drugmakers kick off industry conference with two cancer deals